The central nervous system is acknowledged as a major regulator of both energy and glucose homeostasis. Our data demonstrate that dietary protein restriction increases energy expenditure and improves glucose homeostasis, and that the metabolic hormone FGF-21 coordinates these adaptive responses. However, the tissue site mediating these FGF-21-dependent effects is unclear. In this study, mice with dysfunctional FGF-21 signaling in either the central nervous system (CNS) or adipose tissue were fed a control or low protein (LP) diet to assess changes in body weight and associated metabolic endpoints. We first deleted the required FGF co-receptor beta-Klotho (Klb) from neurons to test whether CNS FGF-21 signaling is required for increased energy expenditure or improved glucose homeostasis in mice consuming a low protein diet. Our data show that LP diet increased energy expenditure (p≤0.01) and reduced body weight (p≤0.001) in control littermates, but these effects were lost in mice bearing CNS-specific deletion of Klb (p=0.65). Protein restriction in the context of a high fat diet also improved glucose tolerance (P≤0.001) and insulin sensitivity (p≤0.001) in control littermates, but these effects were also lost in mice lacking Klb in the CNS. We next tested whether FGF-21 signaling within adipose tissue contributed to the metabolic effects of protein restriction. However, in this case LP diet reduced body weight (p=0.90) and increased food intake (p= 0.98) similarly in control littermates and mice bearing adipose-specific deletion of Klb. Collectively, these data highlight CNS FGF-21 signaling as the first known neuroendocrine mechanism to explain the coordinated metabolic changes induced by dietary protein restriction.

Disclosure

C.M. Hill: None. M.V. Dehner: None. D. McDougal: None. H. Berthoud: None. H. Muenzberg: None. C. Morrison: None.

Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at http://www.diabetesjournals.org/content/license.